Aim: A challenge to the medical care of patients with rheumatoid arthritis (RA) is the management of the wide variety of information, including medication history and disease status, obtained from multiple sources to inform treatment decisions.
| INTRODUCTION
Over the past 10 years, various new biologic/synthetic diseasemodifying antirheumatic drugs have been developed for the treatment of RA, with improved clinical prognosis achieved. In addition, objective and accurate disease monitoring scales have been developed, such as the 28-joint Disease Activity Score 28 (DAS28) (Prevoo et al., 1995) and the Simplified/Clinical Disease Activity Index (SDAI/CDAI) (Anderson, Zimmerman, Caplan, & Michaud, 2011) , to standardize the assessment of disease activity. However, no single measure can serve as a gold standard to assess and monitor all patients with RA.
Therefore, medical experts are required to manage a wide variety of medical information related to patients' health and disease status, as well as medication history, gathered using various forms and patientreported outcomes. Moreover, data collected from various sources, but within the same period, would provide the most accurate information to guide treatment decisions.
Self-report assessment is an important source of information. The Multi-Dimensional Health Assessment Questionnaire (MDHAQ) (Pincus et al., 2010) and Routine Assessment of Patient Index Data 3 (RAPID3) (Pincus, Swearingen, Bergman, & Yazici, 2008a) , which is a composite index calculated from the three RA core data set measures for physical function, pain and patient global estimate, each score 0-10, for a total score range of 0-30 (Pincus, Yazici, & Bergman, 2009) have been shown to correlate with the DAS28 and Clinical Disease Activity Index (CDAI) in clinical trials and in practice settings. Specifically, RAPID3 was found to be comparable with the DAS28 and CDAI for distinguishing patients requiring active versus control treatment in clinical trials evaluating treatment with the antitumour necrosis factor-α inhibitor, adalimumab, and the cytotoxic T-lymphocyte-associated protein 4-immunoglobulin, abatacept (Pincus et al., 2008b) . RAPID3, which is embedded in the MDHAQ (Pincus et al., 2010) , can be reviewed by physicians in only approximately 10 s, compared with the 90 s it takes, on average, to perform the 28-joint count required for the DAS or CDAI (Pincus, Yazici, & Castrejon, 2012) .
RAPID3 provides similar information to the the DAS28 and CDAI in about 5% of the time it takes to perform the latter , and RAPID3 scores for high, moderate and low severity, and remission can be used effectively for treat-to-target in RA (Castrejon et al., 2015; . Therefore, it is clear that RAPID3 is a method by which physicians can gauge the patient's condition with the same precision as, and within a shorter time than, methods such as DAS28 or CDAI. However, it is important to consider that global assessments of disease activity have been criticized for being influenced by patients' age, with these age-dependent effects being independent of joint counts (Ito et al., 2017) . For this reason, multiple parameters of disease activity should be evaluated at the same time.
To achieve this goal, we developed a smart-device-based system for collecting multiple sources of data within the same period, and evaluated the benefits of our system in allowing medical experts to understand the disease and treatment status of patients with RA prior to examination. To our knowledge, this is the first report of an assessment of RA using smart device technology based on cooperation with electronic medical charts in Japan. 
| Smart device system
The smart device system we used was developed by Keigo Ikeda and the DTS Corporation. The system consists of a tablet-style device for patients and a personal computer (PC) for medical staff. The server for this system was on-site on a PC, and the software was built using JavaScript. The tablet software was developed by Objective-C. The system application was developed in such a way that it did not have machine and operating system Our system can be used over a bidirectional connection with the electronic medical chart system in hospitals. However, in the present study, our system was used as stand-alone platform, with no linkage to the electronic medical chart system in Juntendo University Urayasu Hospital and no other internet access included, in order to evaluate the system quality without any effect from other devices or security problems.
| Statistical analyses
We evaluated the correlation between the self-reported MDHAQ and the DAS28-ESR score, which was used as a gold standard (statistical package R, version 3.3.2; available as a free down-load from http:// www.r-project.org). The efficacy of the system was assessed as a decrease in examination time at each visit. A p-value of <0.05 was considered statistically significant.
| RESULTS
The relevant characteristics of the 57 patients enrolled into the study at the start of the trial are summarized in Table 1 . The median age of our study group was 65 (range 34-83) years. The distribution of Steinbrocker's radiological stage (Friedman & Steinbrocker, 1949) was as follows: 22 stage I, 14 stage II, two stage III and 19 stage IV.
The stage number is related to joint damage, with a larger number indicating greater severity. The distribution of Steinbrocker's functional classification (Spector & Hochberg, 1992) was as follows: 42 class 1, 13 class 2 and two class 3, with the two latter patients presenting with severe arthropathy. The class number is related to functional capacity, with a larger number indicating greater severity. The questions used to evaluate patient satisfaction in our smart device system are shown in Table 2 . The majority of patients used the device without difficulty, reporting that use of the smart device was easier than completing hand-written medical forms and questionnaires. All 16 patients in our study group who were older than 70 years were able to use the smart device despite poor eyesight and severe arthropathy. Of note, the majority of patients older than 60 years had never used a smart device before. After receiving instructions, these patients had no difficulty in using the technology and reported that providing information on the tablet was easier than completing hand-written forms. Additionally, all four physicians and three nurses recruited to the study agreed that this system was efficacious for gathering accurate patient-specific information and reducing the burden at clinical visits (data not shown).
Patients improved their speed of data entry on the tablet, with a decrease of 226 to 191 s between the first and second time point of data input, with an improvement of 10 to 40 s as a function of increasing age. We evaluated the correlation between input time and age and disease activity (DAS28-ESR), as shown in Figure. (Table 3) .
| DISCUSSION
Worldwide, the DAS28 and SDAI/CDAI are used as a standard to estimate RA disease activity. Additionally, the 36-item short form survey and the EuroQol are routinely used to measure health-related quality of life (QOL) (Hurst, Kind, Ruta, Hunter, & Stubbings, 1997; Jenkinson, Coulter, & Wright, 1993) . Although obtaining these measures of QOL
is not practical at every visit, this information is important to consider in the objective evaluation of treatment and patient health status (Castrejon, McCollum, Tanriover, & Pincus, 2012) , as well as monitoring change in a chronic disease, such as RA, over time (Castrejon, McCollum, Tanriover, & Pincus, 2012; Castrejon, Pincus, Wendling, & Dougados, 2016 ).
There were some limitations associated with the study due to its noncontrolled nature and the small number of patients enrolled. However, we demonstrated that smart technology provides a feasible way to collect this information, regardless of age, disease status and poor vision, and to provide this information to clinicians prior to the examination. Our system ensured that questions could not be omitted, providing a reliable self-reporting of the MDHAQ/RAPID3, with the accuracy of the data confirmed by the physician at the time of the examination. By providing these data ahead of the examination, physicians were only required to input data on the care provider global health assessment, CRP and ESR to complete the information needed for clinical management. This greatly decreased the burden of gathering data at the time of the examination, both for patients and the medical staff. Our system could also provide physicians with easy access to long-term data tracking for a patient. Moreover, the clinical information was shared with patients on the screen display during the examination in our system. This information sharing could contribute to a confidential relationship with patients and strengthen their motivation for treatment.
Currently, the outpatient follow-up of patients with RA requires that medical staff gain an appreciation of a patient's daily condition from information gathered by self-report health questionnaires and the brief interview at the time of the visit. This is difficult, considering (Grainger, Townsley, White, Langlotz, & Taylor, 2017) . These applications have been shown to be useful for disease self-management (Azevedo, de Sousa, Monteiro, & Lima, 2015) . However, these systems and applications have not been used or tested over bidirectional connection with electronic medical chart systems in hospitals. In contrast to these systems, our system was developed to provide a connected environment with the electronic medical chart system. This is a useful feature for physicians and other medical staff, enabling them to comprehend patients' condition from all the information provided by the smart device system, past medical records and various examination results in the electronic medical record. Future linkage of our system to the electronic medical chart system would allow all pertinent information to be provided to the physician and medical staff prior to the scheduled visit.
In conclusion, our medical support system using smart technology is feasible to be used to provide accurate patient-reported data ahead of a medical visit, which could greatly streamline the medical care of patients with RA, regardless of their age or presence of poor vision and severe arthropathy. Our approach could reduce the burden of the clinical examination for patients and medical staff alike.
